Donor-Recipient Relationship and Risk of ESKD in Live Kidney Donors of Varied Racial Groups.

Kidney donation ancestry biological relationship donor-recipient relationship end-stage renal disease (ESRD) family history of disease health risks kidney failure living-related donor offspring parent race/ethnicity renal transplantation risk of ESRD sibling

Journal

American journal of kidney diseases : the official journal of the National Kidney Foundation
ISSN: 1523-6838
Titre abrégé: Am J Kidney Dis
Pays: United States
ID NLM: 8110075

Informations de publication

Date de publication:
03 2020
Historique:
received: 05 08 2018
accepted: 19 08 2019
pubmed: 17 11 2019
medline: 1 5 2020
entrez: 17 11 2019
Statut: ppublish

Résumé

Risk factors for kidney failure are the basis of live kidney donor candidate evaluation. We quantified risk for end-stage kidney disease (ESKD) by the biological relationship of the donor to the recipient, a risk factor that is not addressed by current clinical practice guidelines. Retrospective cohort study. A cohort of 143,750 US kidney donors between 1987 and 2017. Biological relationship of donor and recipient. ESKD. Donors' records were linked to national dialysis and transplantation registries to ascertain development of the outcome. Donors were observed over a median of 12 (interquartile range, 6-18; maximum, 30) years. Survival analysis methods that account for the competing risk for death were used. Risk for ESKD varied by orders of magnitude across donor-recipient relationship categories. For Asian donors, risks compared with unrelated donors were 259.4-fold greater for identical twins (95% CI, 19.5-3445.6), 4.7-fold greater for full siblings (95% CI, 0.5-41.0), 3.5-fold greater for offspring (95% CI, 0.6-39.5), 1.0 for parents, and 1.0 for half-sibling or other biological relatives. For black donors, risks were 22.5-fold greater for identical twin donors (95% CI, 4.7-107.0), 4.1-fold for full siblings (95% CI, 2.1-7.8), 2.7-fold for offspring (95% CI, 1.4-5.4), 3.1-fold for parents (95% CI, 1.4-6.8), and 1.3-fold for half-sibling or other biological relatives (95% CI, 0.5-3.3). For white donors, risks were 3.5-fold greater for identical twin donors (95% CI, 0.5-25.3), 2.0-fold for full siblings (95% CI, 1.4-2.8), 1.4-fold for offspring (95% CI, 0.9-2.3), 2.9-fold for parents (95% CI, 2.0-4.1), and 0.8-fold for half-sibling or other biological relatives (95% CI, 0.3-1.6). Insufficient sample size in some race and relationship groups. Absence of data for family history of kidney disease for donors biologically unrelated to their recipients. Marked differences in risk for ESKD across types of donor-recipient relationship were observed for Asian, black, and white donors. These findings warrant further validation with more robust data to better inform clinical practice guidelines.

Identifiants

pubmed: 31732232
pii: S0272-6386(19)31013-3
doi: 10.1053/j.ajkd.2019.08.020
pmc: PMC7042071
mid: NIHMS1542839
pii:
doi:

Types de publication

Journal Article Multicenter Study Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

333-341

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK113980
Pays : United States
Organisme : NIDDK NIH HHS
ID : K23 DK103918
Pays : United States
Organisme : NIDDK NIH HHS
ID : K24 DK101828
Pays : United States
Organisme : NIDDK NIH HHS
ID : F32 DK109662
Pays : United States
Organisme : NIDDK NIH HHS
ID : K01 DK101677
Pays : United States
Organisme : AHRQ HHS
ID : K01 HS024600
Pays : United States
Organisme : NIAID NIH HHS
ID : K24 AI144954
Pays : United States
Organisme : NIDDK NIH HHS
ID : K01 DK114388
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK096008
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Références

Kidney Int. 2015 Jul;88(1):17-27
pubmed: 25786098
J Am Soc Nephrol. 2016 Sep;27(9):2885-93
pubmed: 26888476
Am J Transplant. 2017 Feb;17(2):401-410
pubmed: 27434427
Am J Kidney Dis. 2015 Sep;66(3):396-401
pubmed: 26049628
Lancet. 2015 May 16;385(9981):1993-2002
pubmed: 26090645
JAMA. 1984 May 18;251(19):2572-3
pubmed: 6371267
Transplantation. 2015 May;99(5):1023-9
pubmed: 25340609
JAMA. 2014 Feb 12;311(6):579-86
pubmed: 24519297
J Am Soc Nephrol. 2017 Jul;28(7):2180-2187
pubmed: 28280138
Kidney Int. 2004 Dec;66(6):2132-6
pubmed: 15569302
Transplantation. 2005 Mar 27;79(6 Suppl):S53-66
pubmed: 15785361
Am J Transplant. 2007 Oct;7(10):2333-43
pubmed: 17845567
Am J Kidney Dis. 2014 May;63(5):816-9
pubmed: 24518129
Clin J Am Soc Nephrol. 2009 Oct;4(10):1677-84
pubmed: 19713294
Am J Transplant. 2016 Dec;16(12):3568-3572
pubmed: 27588375
Am J Transplant. 2006;6(5 Pt 2):1228-42
pubmed: 16613598
Transplantation. 2017 Aug;101(8S Suppl 1):S1-S109
pubmed: 28742762
J Am Med Assoc. 1956 Jan 28;160(4):277-82
pubmed: 13278189
Am J Transplant. 2014 Aug;14(8):1723-30
pubmed: 25040084
N Engl J Med. 1986 Apr 3;314(14):914-6
pubmed: 3513017
Adv Chronic Kidney Dis. 2014 Sep;21(5):426-33
pubmed: 25168832
Transplantation. 2011 Oct 15;92(7):722-5
pubmed: 21878839
Am J Kidney Dis. 2017 Nov;70(5):619-626
pubmed: 28663061
Transplantation. 2017 Aug;101(8):1783-1792
pubmed: 28737659
N Engl J Med. 2016 Feb 4;374(5):411-21
pubmed: 26544982
J Am Soc Nephrol. 2017 Sep;28(9):2749-2755
pubmed: 28450534
Arch Intern Med. 2009 Feb 23;169(4):342-50
pubmed: 19237717
Am J Transplant. 2018 May;18(5):1129-1139
pubmed: 29392849
J Am Soc Nephrol. 1996 Nov;7(11):2288-313
pubmed: 8959619
Scand J Immunol. 1994 Jan;39(1):1-11
pubmed: 8290887
Clin J Am Soc Nephrol. 2018 Jan 6;13(1):140-152
pubmed: 29242368
Am J Transplant. 2018 Mar;18(3):625-631
pubmed: 28980397
Lancet. 2017 Oct 21;390(10105):1888-1917
pubmed: 28434650
Kidney Int. 2012 Oct;82(7):805-11
pubmed: 22695330
Prog Transplant. 2016 Sep;26(3):203-6
pubmed: 27302054

Auteurs

Abimereki D Muzaale (AD)

Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD. Electronic address: amuzaal1@jhmi.edu.

Allan B Massie (AB)

Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD; Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD.

Fawaz Al Ammary (F)

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.

Macey L Henderson (ML)

Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD; Department of Acute and Chronic Care, Johns Hopkins School of Nursing, Baltimore, MD.

Tanjala S Purnell (TS)

Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD; Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD.

Courtenay M Holscher (CM)

Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.

Jacqueline Garonzik-Wang (J)

Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.

Jayme E Locke (JE)

Department of Surgery, University of Alabama at Birmingham, Birmingham, AL.

Jon J Snyder (JJ)

Scientific Registry of Transplant Recipients, Minneapolis Medical Research Foundation, Minneapolis, MN.

Krista L Lentine (KL)

Saint Louis University Center for Abdominal Transplantation, St. Louis, MO.

Dorry L Segev (DL)

Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD; Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD; Scientific Registry of Transplant Recipients, Minneapolis Medical Research Foundation, Minneapolis, MN.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH